FINANCE

Heart Pump Saves Lives but Raises Costs in Germany

GermanyThu Nov 19 2026

Doctors use a small pump inside the heart to help people with cardiogenic shock after a heart attack. This device can lower the chance of dying within 180 days. But it also leads to more side effects. Researchers looked at whether this pump is a smart buy for Germany's public health insurance system.

They built a computer model that follows patients for the rest of their lives. The model used trial results for the first six months and then tracked long-term heart failure. Money and quality of life were measured in 2023 euros and adjusted by 3 percent each year. The pump gave patients about one extra quality-adjusted year of life. It cost roughly 38,121 euros more. That works out to about 36,083 euros for each extra year of good health. If the insurance system is willing to pay 50,000 euros per year, there is an 86 percent chance the pump is worth it.

The pump also caused more problems. Bleeding happened in 21.8 percent of pump patients compared to 11.9 percent without it. Limb ischemia showed up in 5.6 percent of pump patients versus just 1.1 percent in the other group. These extra harms matter when deciding if the device should be used widely.

One big question remains about hospital payments. The study did not have separate billing data for each treatment group, so it assumed the upfront costs were the same. The net benefit stays positive as long as the hidden payment gap stays under 14,703 euros. This cost work was not done as a standalone project. For now, the pump might be a good value for German statutory health insurance, but only if future billing records clear up that payment difference. The related trial is listed as NCT01633502.

actions